Heparin-induced platelet aggregation is inhibited by antagonists of the thromboxane pathway
- 15 August 1985
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 39 (4) , 533-539
- https://doi.org/10.1016/0049-3848(85)90176-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The electronic aggregometer: A novel device for assessing platelet behavior in bloodPublished by Elsevier ,2002
- Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood plateletsAmerican Journal of Physiology-Heart and Circulatory Physiology, 1985
- Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact plateletsAmerican Journal of Physiology-Heart and Circulatory Physiology, 1985
- Comparison of the effect of a conventional heparin and a low molecular weight heparinoid on platelet function.British Journal of Clinical Pharmacology, 1984
- Effects of heparin and a semi-synthetic heparin analogue on platelet aggregation, lipoprotein lipase and other laboratory tests in surgical patientsThrombosis Research, 1983
- Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1983
- Effect of Heparin and Heparin Fractions on Platelet AggregationJournal of Clinical Investigation, 1980
- Anticoagulant and platelet aggregating activities of heparinThrombosis Research, 1973
- On the Mechanism of Platelet Aggregation Induced by Heparin, Protamine and PolybreneScandinavian Journal of Haematology, 1972
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962